In an in-home interview, participants were queried on use of supplements in the preceding 30 days to estimate the prevalence of use within each NHANES cycle, and trends were evaluated across cycles. Outcomes included use of any supplements; use of multivitamins/multiminerals (MVMM; defined as a product containing Ն10 vitamins and/or minerals); and use of individual vitamins, minerals, and nonvitamin, nonmineral supplements. Data were analyzed overall and by population subgroup (including age, sex, race/ethnicity, and educational status), and were weighted to be nationally representative.
D
ietary supplement products are commonly used by adults in the United States, with prior research indicating an increase in use between the 1980s and mid-2000s. 1, 2 Although often used with an intention of improving or maintaining health, it was estimated that in 2007-2010 only 23% of all supplement products were used at the recommendation of a health care provider. 3 Instead, their use may be motivated, in part, by evidence suggesting that increased intake of some dietary constituents may be associated with reduced risk of outcomes, including cancer and cardiovascular disease. 4, 5 Even so, results from observational studies have yielded mixed results regarding the health benefits of individual supplements or multivitamins/multiminerals (MVMM), and randomized clinical trials have often not supported benefits of these supplements, although the duration of many randomized clinical trials may have been insufficient to observe beneficial effects. [6] [7] [8] [9] [10] Furthermore, some research has indicated that the use of selected supplements at high doses may have adverse effects, 11 generating some skepticism regarding their use. 12 Despite extensive research conducted on the role of dietary supplements in health, little is known about recent trends in supplement use. Most studies describing patterns of use were restricted to older adults, focused on select supplements, were unable to evaluate temporal trends, or did not capture use in the last decade. 1, 2, 13, 14 Using data from the National Health and Nutrition Examination Survey (NHANES), this study was designed to quantify trends in supplement use among US adults from 1999 through 2012, with a focus on use of any supplement products and MVMM, defined as the use of any products containing 10 or more vitamins/minerals, as well as use of individual vitamins, minerals, and nonvitamin, nonmineral (NVNM) supplements.
Methods

Study Population
Participants provided written informed consent and study procedures were approved by the National Center for Health Statistic's research ethics review board. The Memorial Sloan Kettering Cancer Center institutional review board determined that this analysis did not constitute human subjects research, and did not need human subjects approval. This serial cross-sectional study was conducted using data from NHANES, a nationally representative, cross-sectional survey of civilian, noninstitutionalized persons living in the United States. 15 This analysis includes 7 two-year cycles (1999) (2000) through 2011-2012), with 1999-2000 representing the first cycle for which continuous data are available and 2011-2012 representing the most recent cycle for which data are available. Each cycle is an independent sample.
Supplement Use
NHANES participants were first asked if they used any prescription or nonprescription supplements in the prior 30 days. Persons indicating use were asked to show the interviewer the bottles of each supplement product taken (77.4% of supplement products were seen); a supplement product could be a capsule, tablet, pill, softgel, chew or gummy, or other product containing 1 or more supplements. When containers were not seen, participants were asked to recall each product taken. By linking to databases of supplement products and supplement product blends, use of MVMM, vitamins, minerals, and specific supplements was ascertained. More detail is provided in NHANES documentation, 16 and detailed information on how this information was used in analysis is provided in the eMethods in the Supplement. From this information, variables were created for use of any supplement product in the prior 30 days and use of 4 or more supplement products, as well as the use of any vitamin, any mineral, and use of MVMM (defined as a product containing ≥10 vitamins/minerals). 17 This definition was created to capture products labeled as multivitamins in the market place (ie, supplements used by consumers as a nonspecific dietary supplement, commonly containing the recommended daily values of multiple vitamins and typically including minerals). However, this definition did not require any minerals to be in the formulation because several of the most popular multivitamin brands during the period of the surveys did not have minerals. The cutoff of 10 vitamins/minerals was used to separate common MVMMs from more specialized supplements such as vitamin B complex supplements and supplements developed for eye and bone health. However, to allow for comparison to prior NHANES analyses, a secondary MVMM variable, defined as products containing 3 or more vitamins and 1 or more mineral, was also analyzed. 3 Variables were also created corresponding to individual vitamins, minerals, and NVNM supplements. To distinguish how supplements were consumed, results were analyzed both overall (ie, any use) and exclusive of MVMM supplements (eg, vitamin D not from MVMM). This is important because supplements consumed as part of MVMM are often consumed at lower doses than they are in individual or focused combination supplements, and because understanding how supplements are consumed can help inform understanding of trends. Primary analyses focused on any use during the prior 30 days.
Statistical Analyses
The prevalence of supplement use, as determined by selfreported use in the prior 30 days, was assessed within each NHANES cycle. Survey-weighted logistic regression was used to calculate a P value for trend across cycles; the statistical significance of trends was evaluated using a 2-sided test at the α = .05 level. Ratios for the prevalence of use in 2011-2012 vs 1999-2000 are presented. In the presentation of results, a decrease corresponds to a ratio less than 1 and P for trend less than .05; an increase represents a ratio more than 1 and P for trend less than .05; and stable represents a P for trend of .05 or more. The absolute difference in the prevalence of use in 2011-2012 vs 1999-2000 are also presented.
Because most supplemental vitamins/minerals are consumed in the form of MVMM and the total use was of most interest, trends in the Tables are shown for total supplement use. However, results are also presented exclusive of MVMM if the trends with and without MVMM markedly varied. Detailed trends, both overall and exclusive of MVMM, are provided in eTables in the Supplement. Throughout the text, the discussion of trends refers to overall trends in any use of a given dietary supplement (regardless of whether consumed as part of a MVMM), unless otherwise noted.
Although data were analyzed for a large number of supplements, the focus was on supplements fitting the following criteria: (1) a high prevalence of use (>10% during any cycle), and (2) a large change in use over the study period (>3-fold change). Given potential heterogeneity by population subgroup, results are presented by age (20-39 y, 40-64 y, ≥65 y), sex, self-reported race/ethnicity (nonHispanic white, non-Hispanic black, Mexican American), and education (highest attained degree:<high school, high school/some college, ≥4 y of college) Sensitivity analyses were conducted for regular use (defined as use ≥15 days/mo) and age-adjusted trends. To address whether the trends were consistent over the study period, joinpoint regression analyses were conducted and the annual percentage change before and after potential inflection points were calculated using Joinpoint Regression Program Software (National Cancer Institute), version 4.2.0. 18 NHANES is a stratified, complex, multistage probabilitybased survey that oversamples certain groups, and as such, all participants are assigned analytic weights to account for their unequal sampling probability and nonresponse. Analyses were conducted using Stata (College Station), version 13.1.
Results
Over these 7 NHANES cycles, 38 024 adults 20 years or older completed an in-home interview, wherein supplement use was ascertained. Sixty-six persons were excluded due to missing information on supplement use, leaving 37 958 persons (sample size per cycle, 4863-6213). The overall response rate was 74%, with the cycle-specific response rate ranging from 67.4% to 78.3%.
19
In 2011-2012, 52% (95% CI, 49%-55%) of US adults reported using any supplement product in the preceding 30 days ( Use of several NVNM supplements increased ( Table 3 ; eTable 2 in the Supplement). Omega-3 fatty acids increased almost 7-fold, with 1.9% of adults reporting use in 1999-2000 and 13% in 2011-2012 (difference, 11% [95% CI, 9.4%-13%]). Omega-3 fatty acids were the most commonly used NVNM in 2011-2012. This trend was primarily driven by the 9-fold increase in fish oil (1.3% in 1999-2000 vs 12% in 2011-2012; difference, 11% [95% CI, 9.1% to 12%]), although use of alphalinolenic acid or flaxseed also increased. Omega-6 and omega-9 fatty acid supplement use increased, as did use of coenzyme Q10, cranberry, green tea or epigallocatechin gallate, methylsulfonylmethane, and probiotics.
Use of echinacea decreased, as did use of garlic, ginkgo biloba, ginseng, and para-aminobenzoic acid. Use of glucosamine and chondroitin did not significantly change, nor did use of amino acids or fiber.
Trends by age, sex, race/ethnicity, and education were also evaluated (eTables 3-6 in the Supplement). Any supplement use decreased among adults aged 20-39 years, was stable among those aged 40-64 years, and increased among those 65 years or older ( Figure 1 ; eTable 3 in the Supplement). Although women reported more supplement use than men, trends were stable in both groups ( Figure 1 ; eTable 4 in the Supplement). Use of any supplements remained stable among non-Hispanic white adults and Mexican American adults, but increased among non-Hispanic black adults ( Figure 1 ; eTable 5 in the Supplement). Use of supplements remained stable among those with less than a high school education, but decreased among those in higher education groups ( Figure 1 ; eTable 6 in the Supplement).
The overall decrease in use of MVMM was largely driven by a decrease among adults aged 40-64 years, with no change observed among older adults (eTable 3 and eFigure 1 in the Supplement). Use of MVMM decreased significantly among non-Hispanic white adults, but remained stable among nonHispanic black adults and Mexican American adults (eTable 5 and eFigure 1 in the Supplement). Use of MVMM decreased for both men and women (eTable 4 and eFigure 1 in the Supplement) and for all education groups (eTable 6 and eFigure 1 in the Supplement).
Subgroup-specific estimates are presented in Figure 2 for the most commonly used vitamin or mineral, vitamin D, and in eFigure 2 in the Supplement for the most commonly used NVNM, fish oil. Use of vitamin D (exclusive of MVMM) and fish oil increased in all population subgroups. However, when including MVMM, increased use of vitamin D was observed only in those 65 years and older (eTable 3 in the Supplement), women (eTable 4 in the Supplement), and non-Hispanic black adults (eTable 5 in the Supplement). When exploring use among adult women of childbearing age (20-44 years) (eTables 7-8 in the Supplement), use of any supplement products and MVMM decreased. Use of folic acid-containing supplements decreased; however, use of folic acid exclusive of MVMM remained stable.
Trends were relatively comparable for regular use (eTable 9-10 in the Supplement) and when adjusting for age (eTable 11 in the Supplement).
No significant joinpoints were observed for overall supplement use or MVMM (eTable 12 in the Supplement). However, a significant joinpoint, indicating a change in trend, was observed for a number of supplements. Most notably, lycopene increased dramatically prior to 2003-2004 (annual percentage change, 130% [95% CI, 62% to 226%]), decreasing thereafter (annual percentage change, −4.5% [95% CI, −7.2% to −1.6%]). ; however, this study was published in 2012, and would not have influenced our findings. Beyond the decrease for MVMM, a decrease was also observed in use of most vitamins and minerals, including antioxidants vitamins C, E, and selenium. These trends persisted when limited to non-MVMM supplements, indicating that these downward trends were not solely due to the decrease in MVMM use, but also to the decrease in use of individual or smaller combinations containing these antioxidants. This decrease likely reflects increasing skepticism regarding antioxidant supplements, 12 following the publication of studies that demonstrated no or adverse effects on various outcomes. 9, 11, [26] [27] [28] Despite the decrease in MVMM and many vitamins/ minerals, not all decreased. Although overall vitamin D supplement use remained stable, a marked increase in vitamin D supplement use exclusive of MVMM was observed. This indicates that this increase is not due to increased inclusion of vitamin D in MVMM supplements but rather to an increase in individual vitamin D supplements or more focused combinations. This increase aligns with a growing body of research evaluating the potential beneficial effects of vitamin D on a number of health outcomes, including fractures, cancer, cardiovascular disease, and multiple sclerosis. contributing to the increase observed here and in a recent study of older adults.
14 Use of lycopene-containing supplements also increased. A significant joinpoint for lycopene use was observed in 2005-2006, at which time lycopene was used by 25% of men. This increase in the early 2000s followed well-publicized research suggesting that consumption of lycopene-rich tomato products was associated with reduced risk of prostate cancer. 4 This trend was almost entirely driven by MVMM; this increase was due to increased inclusion of lycopene in MVMM formulations, not increased use of individual lycopene supplements. Use of omega-3 fatty acid-containing supplements also increased; this trend was largely driven by an increase in fish oil supplements, although an increase in alphalinolenic acid or flaxseed was also observed. This increase, which has been observed previously, 13, 14 likely reflects increased research and subsequent media attention for the potential benefits of fish or omega-3 fatty acid intake and fish oil supplements on risk of cancer and cardiovascular disease. 5 Not all NVNM supplements increased; many remained stable and a decrease was observed for several, including those that were among the most popular in the early 2000s, 37 including ginseng, ginkgo biloba, and garlic. The decline in ginkgo biloba may be related to a 2002 randomized clinical trial observing no effect of ginkgo biloba on memory function, its primary indication. 38 Furthermore, although glucosamine and chondroitin remained stable, a significant joinpoint was observed in 2005-2006, after which use declined. This may have been due to the 2006 Glucosamine/Chondroitin Arthritis Intervention Trial (GAIT), which found no effect of these supplements on joint structure or function. 8 The trend in any supplement use varied by age, with use decreasing among young adults, stable among middle-aged adults, and increasing among older adults. A recent study of adults aged 62 to 85 years found that supplement use among older adults increased from 51.8% in 2005-2006 to 63.7% in 2010-2011 14 ; an increase among older adults was also observed in our study, but this increase was not observed for other age groups. Use of MVMM decreased significantly among non-Hispanic white adults and more highly educated groups. The reasons for these patterns are unclear. It is possible that the difference in trends in MVMM use by age group may reflect a cohort effect, but a longer time frame would be needed to address this question. It is also possible that differences in trends by population subgroup reflect that research translates into behavior change more quickly in certain population subgroups, 39,40 although differences across subgroups also likely reflect underlying health status and socioeconomic differences. 3 This study has several important strengths. It was conducted using data from a large nationally representative survey. Supplement use was assessed during an in-home interview, in which participants provided detailed information on supplements used over the prior 30 days; supplement bottles were seen for the majority of supplements, likely increasing accuracy of exposure measurement. Furthermore, these data were collected as part of a continuous national survey, allowing for evaluation of trends over a 14-year period.
This study also has several important limitations. First, it was a study of the noninstitutionalized, civilian population, and did not capture use among adults in nursing homes or the military. Second, supplements were assessed in the Non-Hispanic white (P for trend <.001) ≥4 y of college (P for trend <.001)
Less than high school (P for trend <.001)
High school or some college (P for trend <.001)
Data are weighted to be nationally representative. Error bars indicate 95% CIs. [1999] [2000] [2001] [2002] [2003] [2004] [2005] [2006] [2007] [2008] [2009] [2010] [2011] [2012] preceding 30 days, which may have underestimated any use over the preceding year for supplements that may vary seasonally, such as those commonly taken for colds; however, this would not influence the ability to detect trends in use over time.
Research Original Investigation
Third, although the analysis used the most recently available data (through 2011-2012), it is unknown whether or how these findings reflect dietary supplement use at present. Fourth, the study focused on any use in the preceding 30 days, although sensitivity analyses evaluated trends in regular use of supplements. The analyses did not incorporate information on dose, as the intention was to assess prevalence of use in the population use of these supplements, rather than populationlevel exposure. It also did not incorporate information about adherence. Fifth, the serial cross-sectional study design precluded longitudinal measurement of supplement use within the same individuals.
Conclusions
Among adults in the United States, overall use of dietary supplements remained stable from 1999-2012, use of MVMM decreased, and trends in use of individual supplements varied and were heterogeneous by population subgroups.
